The ability to longitudinally track and record molecular events in vivo would provide a 17 unique opportunity to monitor signaling dynamics within cellular niches and to identify critical 18 factors in orchestrating cellular behavior. We present a self-contained analog memory device that 19 enables the recording of molecular stimuli in the form of DNA mutations in human cells. The 20 memory unit consists of a self-targeting guide RNA (stgRNA) cassette that repeatedly directs 21 Streptococcus pyogenes Cas9 nuclease activity towards the DNA that encodes the stgRNA, 22 thereby enabling localized, continuous DNA mutagenesis as a function of stgRNA expression. 23 We analyze the temporal sequence evolution dynamics of stgRNAs containing 20, 30 and 40 24 nucleotide SDSes (Specificity Determining Sequences) and create a population-based recording 25 metric that conveys information about the duration and/or intensity of stgRNA activity. By 26 expressing stgRNAs from engineered, inducible RNA polymerase (RNAP) III promoters, we 27 demonstrate programmable and multiplexed memory storage in human cells triggered by 28 doxycycline and isopropyl β-D-1-thiogalactopyranoside (IPTG). Finally, we show that memory 29 units encoded in human cells implanted in mice are able to record lipopolysaccharide (LPS)-30 induced acute inflammation over time. This tool, which we call Mammalian Synthetic Cellular 31 Recorder Integrating Biological Events (mSCRIBE), provides a unique strategy for investigating 32 cell biology in vivo and in situ and may drive further applications that leverage continuous 33 evolution of targeted DNA sequences in mammalian cells.
memory devices relied on digital switching between two or multiple quasi-stable states based on randomly chosen 30 nt SDS (Construct 8, Table S2 ) but did not detect noticeable self-targeting 138 activity when the cell line was transfected with a plasmid expressing Cas9 (data not shown). We 139 speculated that stgRNAs with longer than 20 nt SDSes might contain undesirable secondary 140 structures that result in loss of activity. Therefore, we computationally designed stgRNAs that 141 were predicted to maintain the scaffold fold of sgRNAs without undesirable secondary 142 structures, such as stem loops and pseudoknots within the SDS (Methods). Stable cell lines 143 encoding stgRNAs containing these computationally designed 30, 40 and 70 nt SDS (Constructs 144 9-11, Table S2 ) were transfected with a plasmid expressing Cas9 driven by the CMV promoter. 145 T7 E1 assays of PCR amplified genomic DNA demonstrated robust indel formation in the 146 respective stgRNA loci (Fig. 1E ). 147 148 stgRNA-encoding loci undergo multiple rounds of self-targeted mutagenesis 149 150 We sought to demonstrate that the stgRNA-encoding DNA locus in individual cells 151 undergoes multiple rounds of self-targeted mutagenesis. To track genomic mutations in single 152 cells over time, we developed a Mutation-Based Toggling Reporter (MBTR) system that 153 generates distinct fluorescence outputs based on indel sizes at the stgRNA-encoding locus, which 154 was inspired by a design previously described for tracking DNA mutagenesis outcomes (11). 155 Downstream of a CMV promoter and a canonical ATG start codon, we embedded the Mutation 156 Detection Region (MDR), which consists of a modified U6 promoter followed by an stgRNA populations, respectively. We then subjected the Gen2R and Gen2G populations to a 2 nd round of 185 FACS. For cells with the stgRNA MBTR, a subpopulation of Gen2R cells toggled into being 186 GFP positive, and similarly, a subpopulation of Gen2G cells toggled into being RFP positive. In 187 contrast, cells containing the non-self-targeting MBTR with a regular sgRNA maintained their 188 original fluorescence signals with no significant toggling behavior observed by FACS analysis 189 ( Fig. 2C, D) . The toggling of fluorescence output observed in UBCp-Cas9 cells transduced with 190 the stgRNA MBTR suggests that repeated mutagenesis resulting in multiple frameshifts in the 191 MDR occurred at the stgRNA locus within single cells. To further corroborate this finding, we 192 sequenced the stgRNA locus in individual cells from post-sorted populations in both rounds of 193 sorting by cloning PCR amplicons into E. coli and performing Sanger sequencing on individual 194 bacterial colonies ( Fig. 2E and Fig. S3A ). We found strong correlations (77%-100% accuracy) 195 between the sequenced genotype and observed fluorescence phenotype in all of the sorted cell 196 populations ( Fig. S3B ). Together, these results confirmed that repetitive mutagenesis can occur 197 at the stgRNA locus within single cells. 198 199 stgRNAs exhibit characteristic sequence evolution patterns 200 201 Having established that stgRNA loci are capable of undergoing multiple rounds of 202 targeted mutagenesis, we set out to delineate their sequence evolution patterns over time. We 203 hypothesized that we could infer characteristic properties associated with stgRNA sequence 204 evolution by simultaneously investigating many independently evolving cell clones, all of which 205 contain an exactly identical stgRNA sequence to start with (Fig. 3C ). We synthesized barcoded 206 plasmid DNA libraries in which the stgRNA sequence was maintained constant while a 207 chemically randomized 16 bp barcode was placed immediately downstream of the stgRNA (Fig. 208 3A). Six separate DNA libraries were synthesized that encode stgRNAs containing six unique 209 SDSes of different lengths: 20nt-1, 20nt-2, 30nt-1, 30nt-2, 40nt-1, or 40nt-2 (Constructs 19-24, 210 Table S2 ). We used a constitutively expressed blue fluorescent protein, EBFP2, to confirm an 211 MOI of ~0.3 so that most of the infected cells should contain single-copy integrants. 212 On day 0, lentiviral particles encoding each of the six stgRNA libraries were used to 213 infect 200,000 UBCp-Cas9 cells in six separate wells of a 24-well plate. At a target MOI of 0.3, 214 the infections resulted in ~60,000 successfully transduced cells per well. For each stgRNA 215 library, eight cell samples were collected at time points approximately spaced 48 hours apart 216 until day 16 ( Fig. 3B ). All samples from eight different time points across the six different 217 libraries were pooled together and sequenced via Illumina NextSeq. After aligning the next- 218 generation sequencing reads to reference DNA sequences (Methods), 16 bp barcodes that were 219 observed across all the time points and the corresponding upstream stgRNA sequences were 220 identified ( Fig. S4A ). For each of the stgRNA libraries, we found >10 4 unique 16 bp barcoded 221 loci that were observed across all of the eight time points (Fig. S4B ). The aligned stgRNA 222 sequence variants were represented with words composed of a four-letter alphabet: at each bp 223 position, the stgRNA sequence was represented by either M, I, X or D, which stand for match, 224 insertion, mismatch, or deletion, respectively ( Fig. S4C , D, Methods). We identified >1000 225 unique sequence variants that were observed in any of the time points and any of the barcoded 226 loci for each stgRNA (Fig. S5A , stgRNA sequences in Table S1 ). Although some sequence 227 variants are found in common across the stgRNAs, majority of the sequence variants are unique 228 to each stgRNA. 229 We plotted the number of barcoded loci associated with each unique sequence variant 230 derived from the original 30nt-1 stgRNA for three different time points (Fig. 3D ). Although the 231 majority of the barcoded loci contained the original un-mutated stgRNA sequence (Index #1) for 232 all three time points, we observed that a sequence variant containing an insertion at bp 29 (Index 233 #523) and another sequence variant containing insertions at bps 29 and 30 (Index #740) gained 234 significant representation by day 14. We noticed that most of the barcoded stgRNA loci evolved 235 into just a few major sequence variants and thus sought to determine if these specific sequences 236 would dominate across different experimental conditions. In Fig. S5B , we present the top seven 237 most abundant sequence variants of the 30nt-1 stgRNA observed in three different experiments 238 discussed in this work. The three experiments were performed with the 30nt-1 stgRNA encoded 239 and: (1) tested in vitro in a HEK 293T-derived cell line (UBCp-Cas9), (2) tested in vitro in a 240 HEK 293T-derived cell line in which Cas9 was regulated by the NF-κB-responsive promoter 241 (inflammation-recording cells), or (3) tested in vivo in inflammation-recording cells ( Fig. 3F , 4E 242 and 4G, respectively). We found that six sequence variants (including Index #523 and #740) 243 were represented in the top seven sequence variants for all three different experiments we 244 performed with the 30nt-1 stgRNA. Moreover, even though we observed >1000 unique sequence 245 variants for 30nt-1 stgRNA ( Fig. S5A , stgRNA sequences in Table S1 ), these top seven most 246 abundant sequence variants constituted >85% of the total sequences represented in each of these 247 experiments. Thus, we speculate that stgRNA activity can result in specific and consistent 248 mutations. 249 Given our observation that stgRNAs may have characteristic sequence evolution patterns, 250 we sought to infer the likelihood of an stgRNA locus transitioning from any given sequence 251 variant to another variant due to self-targeted mutagenesis. We computed such likelihoods in the 252 form of a transition probability matrix, which captures the probability of a sequence variant 253 transitioning to any sequence variant within a given time frame ( Fig. 3E , Methods). Briefly, for 254 every sequence variant observed in a future time point (daughter), a sequence variant from the 255 immediately preceding time point and with the same barcode was chosen as the likely parent 256 based on a minimal Hamming distance metric. Such parent-daughter associations were computed 257 and normalized across all time points and barcodes to result in the transition probability matrix. 258 In Fig. 3E , we present the transition probabilities of the top 100 most frequent sequence variants 259 of the 30nt-1stgRNA. At each (x, y) position, we present the likelihood of a sequence variant 260 from the y-axis (row) mutagenizing into a sequence variant on the x-axis (column) within a 2-261 day time frame. Since the presence of PAM is an absolute requirement for self-targeting activity, 262 we only present the transition probabilities for sequences on the y-axis containing an intact 263 PAM. From left to right on the x-axis and bottom to top on the y-axis in Fig. 3E , the sequence 264 variants are arranged in order of decreasing distance between the mutated region and the PAM. 265 When the distances are the same, the sequence variants are arranged in order of increasing 266 deletions. We found that self-targeting sequence variants were generally more likely to remain 267 unchanged than be mutagenized across the two-day time period, as indicated by high 268 probabilities along the main diagonal (matrix elements where x=y) as annotated on Fig. S6 . In 269 addition, transition probability values were typically higher for sequence transitions below the 270 main diagonal versus for those above the main diagonal, implying that sequence variants tend to 271 progressively gain deletions ( Fig. S6 ). Moreover, when compared with deletion-containing 272 sequence variants, insertion-containing sequence variants tended to have a very narrow set of 273 sequence variants they were likely to mutagenize into. Finally, we noticed that the predominant 274 way in which mutated self-targeting sequence variants mutagenize into non-self targeting 275 sequence variants is by losing the PAM and downstream region encoding the stgRNA handle 276 while keeping the SDS encoding region intact. 277 Having analyzed the sequence evolution characteristics of stgRNAs, we envisioned that a 278 metric could be computed based on the relative abundance of stgRNA sequence variants as a 279 measure of stgRNA activity. Such a metric would enable the use of stgRNAs as intracellular 280 recording devices in a population to store biologically relevant, time-dependent information that 281 could be reliably interpreted after the events were recorded. From our analysis of stgRNA 282 sequence evolution, we reasoned that novel self-targeting sequence variants at a given time point 283 should have arisen from prior self-targeting sequence variants and not from non-self-targeting 284 sequence variants. Thus, we calculated the percentage of sequences that contain mutations only 285 in the SDS-encoding region amongst all the sequences that contain an intact PAM, which we call 286 the percent mutated stgRNA, to serve as an indicator of stgRNA activity. In Fig. 3F , we plot the 287 percent mutated stgRNA as a function of time for the six different stgRNAs. Except for the 20nt- 288 2 stgRNA, which saturated to ~100% by 10 days, we observed non-saturating and steadily 289 increasing responses of the metric for all stgRNAs over the entire 16-day experimentation 290 period. Based on the rate of increase of the percent mutated stgRNA (percent mutated stgRNA / 291 time), we note that stgRNAs encoding SDSes of longer length should have a greater capacity to 292 maintain a steady increase in the recording metric for longer durations of time and thus should be 293 more suitable for longer-term recording applications. 294 We also conducted a time course experiment with regular sgRNAs targeting a DNA 295 target sequence to test their ability to serve as memory registers (Fig. S7 ). We used sgRNAs 296 encoding the same 20nt-1, 30nt-2 and 40nt-1 SDSes tested in Fig. 3F (Constructs 25-27, Table   297 S2) and found that unlike stgRNA loci, sgRNA target loci quickly saturate the percent mutated 298 sequence metric and exhibit restricted linear ranges.
300
Small-molecule inducible and multiplexed memory storage using mSCRIBE 301 302 We placed stgRNA loci under the control of small-molecule inducers to record chemical 303 inputs into genomic memory registers. We designed doxycycline-inducible and isopropyl-β-D-304 thiogalactoside (IPTG)-inducible RNAP III promoters to express stgRNAs, similar to prior work 305 with shRNAs (12, 13) ( Fig. 4A ). We engineered the RNAP III H1 promoter to contain a Tet-306 operator, allowing for tight repression of promoter activity in the presence of the TetR protein, 307 which can be rapidly and efficiently relieved by the addition of doxycycline (Construct 29, Table   308 S2). Similarly, we built an IPTG-inducible stgRNA locus by introducing three LacO sites into 309 the RNAP III U6 promoter so that LacI can repress transcription of the stgRNA, which is 310 relieved by the addition of IPTG (Construct 30, Table S2 ). We first verified that doxycycline and 311 IPTG-inducible stgRNAs worked independently when integrated into the genome of UBCp-Cas9 312 cells that also express TetR and LacI (Construct 28, Table S2 ) ( Fig. S8 ). Next, we placed the 313 doxycyline and IPTG-inducible stgRNA loci on to a single lentiviral backbone ( Fig. 4A , 314 Construct 31 in Table S2 ) and integrated them into the genome of UBCp-Cas9 cells that also 315 expressed TetR and LacI. The induction of stgRNA expression by exposure to doxycycline or 316 IPTG led to efficient self-targeting mutagenesis at the cognate loci as detected by the T7 E1 317 assay, while lack of exposure to doxycycline or IPTG did not ( Fig. 4B ). Moreover, when cells 318 were exposed to both doxycycline and IPTG, we detected simultaneous mutation acquisition at 319 both loci, thus demonstrating inducible and multiplexed molecular recording across the cell 320 populations. 323 324 We next sought to build stgRNA memory units that record signaling events in cells 325 within live animals. We adapted a well-established acute inflammation model involving 326 repetitive intraperitoneal (i.p.) injection of lipopolysaccharide (LPS) in mice (14). Immune cells 327 that sense LPS release tumor necrosis factor alpha (TNFα), which is a potent activator of the NF- Table S2 ) and stably integrated it into HEK 293T cells. We 332 observed a >50-fold increase in expression levels when these cells were exposed to TNFα in 333 vitro ( Fig. S9A , B, C). Next, we implanted these cells into the flanks of athymic nude mice Recording LPS-inducible inflammation in vivo via mSCRIBE 351 352 After characterizing the in vitro time and dosage sensitivity of our inflammation 353 recording cells, we implanted them into mice. The implanted mice were split into three cohorts: 354 no LPS injection over 13 days, an LPS injection on day 7, and an LPS injection on day 7 355 followed by another LPS injection on day 10 ( Fig. 4F ). The genomic DNA of implanted cells 356 was extracted from all cohorts on day 13. The stgRNA locus was PCR amplified and sequenced 357 via next-generation sequencing. We observed a direct correlation between the LPS dosage and 358 the percent mutated stgRNA metric, with increasing numbers of LPS injections resulting in 359 increased percent mutated stgRNA metric (also see Fig. S5B ). Our results indicate that stgRNA 360 memory registers can be used in vivo to record physiologically relevant biological signals in an 361 analog fashion. 362 In Fig. 3E and 4F, we used PCR to amplify the stgRNA loci from ~30,000 cells and then 363 calculated the percent mutated stgRNA metric as a readout of genomic memory. However, 364 access to tissues or biological samples could be limited in certain in vivo contexts. To investigate 365 the sensitivity of our stgRNA-encoded memory when the input biological material is restricted, we sampled 1:100 dilutions of the genomic DNA extracted from the TNFα-treated 367 inflammation-recording cells in Fig. 4E (which corresponds to ~300 cells) in triplicate followed 368 by PCR amplification, sequencing, and calculation of the percent mutated stgRNA metric (Fig. 369 S10). We found very little deviation between the percent mutated sgRNA metric between 370 samples with ~300 cells versus those from ~30,000 cells. We hypothesize that this tight 371 correspondence is due to stgRNA evolution towards very few, dominating sequence variants, as 372 was observed in Fig. 3D and Fig. S5B . 373 374 Discussion and Conclusions 375 376 In this paper, we describe a novel architecture for self-targeting guide RNAs (stgRNAs) 377 that can repeatedly direct Cas9 activity against the DNA loci that encode the stgRNAs. This 378 technology enables the creation of self-contained genomic analog memory units in human cell 379 populations. We show that stgRNAs can be engineered by introducing a PAM into the sgRNA 380 sequence, and validate that mutations accumulate repeatedly in stgRNA-encoding loci over time 381 with our MBTR system. After characterizing the sequence evolution dynamics of stgRNAs, we 382 derive a computational metric that can be used to map the extent of stgRNA mutagenesis in a 383 cell population to the duration or magnitude of the recorded input signal. Our results demonstrate 384 that the percent mutated stgRNA metric increases with the magnitude and duration of input 385 signals, thus resulting in long-lasting analog memory stored in the genomic DNA of human cell 386 populations. 387 Because the stgRNA loci can be multiplexed for memory storage and function in vivo, this 388 approach for analog memory in human cells could be used to map dynamical and combinatorial 389 sets of gene regulatory events without the need for continuous cell imaging or destructive 390 sampling. For example, cellular recorders could be used to monitor the spatiotemporal 391 heterogeneity of molecular stimuli that cancer cells are exposed to within tumor 392 microenvironments (18), such as exposure to hypoxia, pro-inflammatory cytokines, and other 393 soluble factors. One could also track the extent to which specific signaling pathways are 394 activated during disease progression or development, such as the mitogen-activated protein 395 kinase (MAPK), Wnt, Sonic Hedgehog (SHH), and TGF-β regulated signaling pathways (19-396 22). 397 One limitation of our approach is that the NHEJ DNA repair mechanism is error-prone, so 398 it is not easy to precisely control how each stgRNA cleavage event translates into a defined 399 mutation, which could result in errors and noise in interpreting a given memory register. Ideally, 400 each stgRNA cleavage event would result in a defined mutation, rather than a range of 401 mutations. Amongst NHEJ repair mechanisms, recent studies have identified a more error-prone 402 repair pathway, termed alternative NHEJ (aNHEJ). To enhance the controllability of mutations 403 that arise over time, small molecule inhibitors of aNHEJ components, including ligase III and 404 PARP1 could be used (23, 24). The systematic engineering and characterization of a larger 405 library of stgRNA sequences could also help to identify memory registers that are more efficient 406 than the ones tested here. 407 Moreover, since our system generates a diverse set of stgRNA variants during the self-408 mutagenesis process, it is difficult to predict and eliminate potential off-target effects that may 409 arise even if the original stgRNA can be designed for minimal off-target effects. As an 410 alternative, we could fuse deactivated Cas9 (dCas9) to DNA cleavage domains such as single 411 chain FokI nucleases (25) so that dCas9 could be targeted to a specific DNA locus with cleavage 412 occurring away from the dCas9 binding site. This way, one can avoid generating new variants of 413 stgRNAs that might target other sites in the genome while repeated targeting of the DNA locus 414 can occur at locations distal to the dCas9 binding site, hence serving as a continuous memory 415 register. Alternatively, adopting the recently described 'base-editing' strategy that employs 416 cytidine deaminase (26) activity could help to avoid issues with using mutagenesis via DNA 417 double strand breaks for memory storage. Epigenetic strategies, for example by fusing 418 methyltransferases (27) or demethylases (28) to dCas9, could also be leveraged for continuous 419 memory storage. Finally, in addition to recording information, this technology could be used for 420 lineage tracing in the context of organogenesis. Embryonic stem cells containing stgRNAs could 421 be allowed to develop into a whole organism and the resulting lineage relationships between 422 multiple cell-types could be delineated via in situ RNA sequencing (29). In summary, we show 423 that that mSCRIBE, enabled by self-targeting CRISPR-Cas, is useful for analog memory in 424 mammalian cells. We anticipate that mSCRIBE will be applicable to a broad range of biological 425 settings and should provide unique insights into signaling dynamics and regulatory events in cell 426 populations within living animals. 1  193  234  248  260  280  287  294  301  304  321  327  332  337  355  373  423  465  479  483  498  505  509  518  523  581  599  627  668  689  713  720  740  784  836  878  897  910  934  943  946  957  965  976  1004  1023  1051  1081  1140  1166  1195  1203  1230  1242  1251  1262  1283  1311  1412  1428  1498  1615  1692  1777  1816  1872  1898  1913  1919  2036  2086  2093  2187  2201  2221  2252  2288  2326  2365  2400  2414  2443  2468  2488  2511  2539  2562  2579  2598  2618  2643  2654  2663  2676  2684  2694  2701  2707  2712  2713 Graphical respresentation of 30nt-1 stgRNA sequence variants 1  193  234  248  260  280  287  294  301  304  321  327  332  337  355  373  423  465  479  483  498  505  509  518  523  581  599  627  668  689  713  720  740  784  836  878  897  910 
Recording the activation of the NF-κ κB pathway via mSCRIBE
Deletion G G U U U U U U U U A A U U A A A A A A A A U U A A A G G C U A U A G C A A G U G A A A G G C U A G U C C G U A U C A U C U U U U U U U U U C C C C C A A A A A A G GG G G G G G G A A U U A A A A G G U U C C G GG G A A G G U U A A C C U U G G U U C C C C U U G G G G G G G G U U U U A A U U A A A A C C C C U U mod2 C C G G G G U U U U A A U U A A A A C C C C G G mod3 G G G G U U U U U U U U A A U U A A A A A A A A U U mod4 G G G G U U U U U U U U A A U U A A A A A A A A U U mod5 G G U U U U U U U U A A U U A A A A A A A A U U WT G G U U U U A A U U A A A A A A A A U U mod1 G G G G U22, U23 Non transfected mYFP Cas9 WT mod1 mod2 mod3 mod4 mod5 mod5 mod4 mod3 mod2 mod1 WT mod5 mod4 mod3 mod2 mod1 WT28 bp del (F2) TTGACTTGCAAT----------------------------AGATGAGATGAATCGGTGTT 10 bp del (F2) TTGACTTGCAATTTCTTGCTCCAACCCTGTTG----------ATGAGATGAATCGATGTT 19 bp del (F2) TTGACTTGCAATTTCTTGCTCCAA-------------------TGAGATGAATCGGTGTT 13 bp del (F2) TTGACTTGCAATTTCTTGCTCCAACCCT-------------GATGAGATGAATCGGTGTT 19 bp del (F2) TTGACTTGCAATTTCTTGCTCC-------------------GATGAGATGAATCGATGTT 1 bp del (F2) TTGACTTGCAATTTCTTGCTCCAACCCTGT-GTTTCTGATAGATGAGATGAATCGGTGTT 23 bp del (F3) TTGACTTGCAATTTCTTGCTCCAACCCTGTT-----------------------GGTGTT 1 bp ins (F3) TTGACTTGCAATTTCTTGCTCCAACCCTGTTTGTTTCTGATAGATGAGATGAATCGGTGTT 11 bp del (F3) TTGACTTGCAATTTCTTGCTCCA-----------TCTGATAGATGAGATGAATCGGTGTT 1 bp ins (F3) TTGACTTGCAATTTCTTGCTCCAACCCTGTTTGTTTCTGATAGATGAGATGAATCGGTGTT 1 bp ins (F3) TTGACTTGCAATTTCTTGCTCCAACCCTGTTTGTTTCTGATAGATGAGATGAATCGGTGTT 8 bp del (F3) TTGACTTGCAATTTCTTGCTCC--------TGTTTCTGATAGATGAGATGAATCGGTGTT 14 bp del (F3) TTGACTTGCAATTTCTTGCTCCAACCCTGT--------------GAGATGAATCGGTGTT 14 bp del (F3) TTGACTTGCAATTTCTTG--------------TTTCTGATAGATGAGATGAATCGGTGTT 8 bp del (F3) TTGACTTGCAATTTCTTGCTCCAACCCTGTT--------TAGATGAGATGAATCGGTGTT 16 bp del (F2) TTGACTTGCAATTTCTTGCTCCAACCC----------------TGAGATGAATCGGTGTT 4 bp del (F2) TTGACTTGCAATTTCTTGCTCCAACCCTGTTGTTTCTGATAGA----ACGAATCGGTGTT 28 bp del (F2) TTGACTTGCAATTTCT----------------------------GGGNCGAATCGGGGTT
Materials and Methods

Vector construction
The vectors used in this study (Table S2) 
Cell culture, transfections and lentiviral infections
Cell culture and transfections were performed as described earlier (1). HEK 293T cells (ATCC CRL-11268) were purchased from and authenticated by ATCC. Our cell lines were tested negative for mycoplasma contamination by the Diagnostic Laboratory of the Division of Comparative Medicine at MIT. Lentiviruses were packaged using the FUGw backbone (2) (Addgene #25870) in HEK 293T cells.
Filtered lentiviruses were used to infect respective cell lines in the presence of polybrene (8 µg/mL).
Successful lentiviral integration was confirmed by using lentiviral plasmid constructs constitutively expressing fluorescent proteins or antibiotic resistance genes to serve as infection markers.
Clonal cell lines and DNA constructs
A lentiviral plasmid construct expressing spCas9, codon optimized for expression in human cells fused to the puromycin resistance gene with a P2A linker was built from the taCas9 plasmid (1) (Construct 12, Table S2 ). The UBCp-Cas9 cell line was constructed by infecting early passage HEK 293T cells with high titre lentiviral particles encoding Construct 12 and selecting for clonal populations grown in the presence of puromycin (7 µg/mL). The NF-κBp-Cas9 cell line was built by infecting HEK 293T cells with high titer lentiviral particles encoding a NF-κB-responsive Cas9 expressing construct (Construct 33, Table S2 ). Transduced cells were induced with 1 ng/mL TNFα for three days followed by selection with 3 µg/mL puromycin. NF-κBp-Cas9 cells were then clonally isolated in the absence of TNFα. NF-κBp-Cas9 cells were infected with lentivirus particles encoding the 30nt-1 stgRNA locus at 0.3 multiplicity of infection (MOI) to build inflammation-recording cells. Cell lines used to test stgRNA activity were built by infecting HEK 293T cells with lentiviral particles encoding constructs 1 through 6 ( Finally, the counts were normalized such that the total likelihood of transitioning from each parent to all possible daughters would sum to one. The Hamming distance metric between two sequence variants in the 'MIXD' format was calculated by assigning a distance score for each base pair position.
Specifically, if only one of the sequence variants being compared had an insertion at a particular base pair position, then the score for that position is assigned 2. In all other cases, the score at a base pair position was assigned 0 if the sequence variant letters were identical and 1 if they were not identical.
The scores for each base pair position were summed up and used as the Hamming distance metric between the two sequence variants. Finally, while assigning parent-daughter associations, unless the parent and the daughter sequence variants were exactly identical, sequence variants that contain mutations in the PAM were not considered as potential parents.
Design of longer stgRNAs
Longer stgRNAs were designed using the ViennaRNA package (5) . Specifically, the RNAfold software was used to generate SDSes that retain the native structure of the guide RNA handle and no secondary structures in the SDS encoding region in the minimum free energy structure.
In vivo inflammation model
Four to six weeks old female athymic nude mice (strain nu/nu) were obtained from the rodent breeding colony at Charles River Laboratory. They were specific pathogen free and maintained on sterilized water and animal food. All animals were maintained and used in accordance with the guidelines of the Institutional Animal Care and Use Committee. Sample sizes of the study were estimated based according to in vivo pilot studies and in vitro studies on the expected variance between animals and assay sensitivity. Inflammation-recording cells were suspended in matrigel (Corning, NY) in 1:1 ratio with cell growth media. 2 x10 6 cells were implanted subcutaneously in the flank regions of mice.
Animals were randomly assigned into experimental groups after tumor implantation with matched tumor sizes. Where indicated, mice were injected intraperitoneally with lipopolysaccharide (LPS) (from Escherichia coli serotype 0111:B4, prepared by from sterile ready-made solution from Sigma Chemical Co., St. Louis, MO) dissolved in 0.1 ml saline solution. Animal studies were conducted without blinding. The exclusion and inclusion criteria of the animal study were pre-established. Animals with tumors that grew more than 10 mm in its largest diameter during the experimental period were sacrificed and excluded from the study.
Code availability
Relevant C++ routines used for data analysis can be found at:
http://www.rle.mit.edu/sbg/resources/stgRNA/ password: stgRNA GGAAAGGACGAAACACCGTAAGTCGGAGTACTGTCCT GGG TTAGAGCTAGAAATAGC   indel #2  GGAAAGGACGAAACACCGTAAGTCGGAGTA  CT GGG TTAGAGCTAGAAATAGC  indel #3  GGAAAGGACGAAACACCGTAAGTCGGAGTAC  T GGG TTAGAGCTAGAAATAGC  indel #4  GGAAAGGACGAAACACCGTAAGTCGGAGTACT  GGG TTAGAGCTAGAAATAGC   indel #7  GGAAAGGACGAAACACCG  T GGG TTAGAGCTAGAAATAGC   indel #1  GGAAAGGACGAAACACCGTAAGTCGGAGTACTG CCT GGG TTAGAGCTAGAAATAGC   indel #5  GGAAAGGACGAAACACCGTAAGTCGGAGTACTG  TTAGAGCTAGAAATAGC  indel #6  GGAAAGGACGAAACACCGTAAGTCGGAGTACTG  GG TTAGAGCTAGAAATAGC   +1 Table S2 ). We integrated these constructs into the genome of HEK 293T cells that do not express Cas9 via lentiviral infections at 0.3 MOI. We observed the expected correspondence between indel sizes in the MDR and fluorescence outputs as shown with flow cytometry analysis (top) and fluorescent microscopy (bottom). Also see Fig.   2A . (UBCp-Cas9 cells) were infected with lentiviral particles encoding the self-targeting MBTR construct at low titre. After 5 days, cells were sorted into RFP and GFP positive cells (Gen1:RFP and Gen1:GFP).
The genomic DNA was extracted from half of the sorted cells, and stgRNA loci were amplified and cloned into E. coli. Individual bacterial colonies were then sequenced via Sanger sequencing (Methods).
The other half of the sorted cells was allowed to grow and after a week from the initial sort, the cells were sorted again. The stgRNA loci of the harvested cells (Gen2R:RFP, Gen2R:GFP, Gen2G:RFP and Gen2G:GFP) were Sanger sequenced in a similar fashion. (A) Sanger sequencing data of each cell population. For each sequence, a description of the mutation is provided on the left annotated with reading frame ( Fig. 2A ). The descriptions indicated in red are mutations that do not correspond to the expected phenotype. We predominantly observed insertion sizes of only one or two bps but a wide range of deletion sizes. (B) We observed >80% match between the observed stgRNA sequence variant and the corresponding fluorescence phenotype in our samples. We speculate that the lack of perfect correspondence between the stgRNA sequence variant genotype and the fluorescence phenotype could be due to delays in the switching of cellular fluorescence following very recent self-targeted mutagenesis. Such delays could arise from the long half-lives of GFP and RFP (~24 hrs) and/or the time lag associated with gene expression. Also see Fig. 2 . S4C, D). The sequence variants presented above are the top 7 most frequently observed sequence variants of 30nt-1 stgRNA in three different experiments. The three experiments were performed with the 30nt-1 stgRNA encoded and: (1) tested in vitro in a HEK 293T-derived cell line (UBCp-Cas9), (2) tested in vitro in a HEK 293T-derived cell line in which Cas9 was regulated by the NF-kB-responsive promoter (inflammation-recording cells), or (3) tested in vivo in inflammation-recording cells respectively (Fig. 3F, 4E x-axis and bottom to top on the y-axis, the sequence variants are arranged in order of decreasing distance between the mutated region and the PAM. When the distances are the same, the sequence variants are arranged in order of increasing deletions. The highlighted features, Feature 1 and Feature 2, convey characteristic aspects of 30nt-1 stgRNA sequence evolution. In Feature 1, we observe that the transition probability values for transitions on the main diagonal (matrix elements that have x=y) are higher than those that are not on the main-diagonal, implying that the 30nt-1 stgRNA variants do not mutagenize much over a 48-hr time frame. We also observe that the transition probability values in the highlighted lower triangle (below the main-diagonal) are higher than the ones in the highlighted upper triangle (above the main-diagonal). This implies that 30nt-1 stgRNA sequence variants have a higher propensity to progressively gain deletions. In Feature 2, we observe that transition probability values are higher along the values indicated by the ovals. This implies that each of the mutated, self targeting stgRNA variants transition into non-self-targeting variants via mutagenic events that result in deletions of the downstream PAM sequences while keeping the upstream SDS-encoding regions intact. We also noticed that sequence variants containing insertions (highlighted by the red arrows) have a very narrow range of sequence variants they mutate into, compared with those that contain deletions. Also see Fig. 3E . Table S2 ). The doxycycline-inducible stgRNA cassette was introduced into UBCp-Cas9 cells also expressing TetR and LacI. The cells were grown in the presence or absence of 500 ng/mL of doxycycline for 4 days and then assayed for self-targeted mutagenesis. The cleavage fragments observed from T7 E1 mutation detection assay showed that stgRNA activity was regulated by doxycycline. (C-D) Similarly, an IPTG-inducible stgRNA construct was built by introducing three copies of Lac operator within the U6 promoter (Construct 30, Table S2 ). The IPTG-inducible stgRNA cassette was introduced into UBCp-Cas9 cells also expressing TetR and LacI. The cells were grown in the presence or absence of 2 mM IPTG for 4 days and then assayed for self-targeted mutagenesis. In the presence of IPTG, mutations were detected in the stgRNA locus by the T7 E1 assay. Also see Fig. 4A , B and Constructs 28-31 in Table S2 . corresponding to ~300 inflammation-recording cells, compared with the same metric measured from 30,000 inflammation-recording cells. Genomic DNA was harvested from inflammationrecording cells exposed to 1000 pg/mL TNFα in a 24-well plate. Half of the genomic DNA material (corresponding to ~30,000 cells) from the total genomic DNA per well (which was extracted from ~60,000 successfully infected cells) was PCR amplified and sequenced via next-generation sequencing.
In addition, three samples of 1:100 dilutions of the genomic DNA obtained from the remaining half of the genomic DNA (corresponding to ~300 cells) were PCR amplified and sequenced via next-generation sequencing. The percent mutated stgRNA metric was calculated and plotted. We observed that as few as 300 cells can provide an accurate readout of the percent mutated stgRNA metric compared with 30,000 cells. Also see Fig. 4E .
